Medmira Inc(MMIRF)

Description: MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, and the Asia Pacific. The company's research is focused on specific areas of the diagnostics market, such as rapid, point-of-care, and in vitro sectors. It offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. The company also provides Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; and Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis. In addition, it offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its products through a network of medical distributors and strategic business development partners with customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of OnSite Lab Holdings AG.

---

Keywords: Medicine Biotechnology Antibodies Public Health E Health Antibody Hepatitis HIV Hepatitis B Bacteria Blood Multiplex Elisa Immunologic Tests Sexually Transmitted Diseases And Infections Serum Syphilis Helicobacter Pylori Helicobacter Testing Solutions

---

Home Page: www.medmira.com

155 Chain Lake Drive
Halifax, NS B3S 1B3
Canada
Phone: 902 450 1588

---

Officers

Exchange: PINK

Country: US

Currency: US Dollar ($)